PML nuclear bodies and chromatin dynamics: catch me if you can!

A Corpet, C Kleijwegt, S Roubille, F Juillard… - Nucleic Acids …, 2020 - academic.oup.com
Eukaryotic cells compartmentalize their internal milieu in order to achieve specific reactions
in time and space. This organization in distinct compartments is essential to allow …

Neurofibromin structure, functions and regulation

M Bergoug, M Doudeau, F Godin, C Mosrin, B Vallée… - Cells, 2020 - mdpi.com
Neurofibromin is a large and multifunctional protein encoded by the tumor suppressor gene
NF1, mutations of which cause the tumor predisposition syndrome neurofibromatosis type 1 …

Improved outcomes with retinoic acid and arsenic trioxide compared with retinoic acid and chemotherapy in non–high-risk acute promyelocytic leukemia: final results …

U Platzbecker, G Avvisati, L Cicconi… - Journal of Clinical …, 2017 - ascopubs.org
Purpose The initial results of the APL0406 trial showed that the combination of all-trans-
retinoic acid (ATRA) and arsenic trioxide (ATO) is at least not inferior to standard ATRA and …

Retinoic acid receptors: from molecular mechanisms to cancer therapy

A Di Masi, L Leboffe, E De Marinis, F Pagano… - Molecular aspects of …, 2015 - Elsevier
Retinoic acid (RA), the major bioactive metabolite of retinol or vitamin A, induces a spectrum
of pleiotropic effects in cell growth and differentiation that are relevant for embryonic …

PML nuclear bodies: from architecture to function

V Lallemand-Breitenbach, H de Thé - Current opinion in cell biology, 2018 - Elsevier
PML nuclear bodies are nucleated by the PML protein, which polymerizes into spherical
shells where it concentrates many unrelated partner proteins. Emerging data has connected …

SUMOylation-mediated regulation of cell cycle progression and cancer

K Eifler, ACO Vertegaal - Trends in biochemical sciences, 2015 - cell.com
Protein conjugation with Small ubiquitin-like modifier (SUMOylation) has critical roles during
cell cycle progression. Many important cell cycle regulators, including many oncogenes and …

Acute promyelocytic leukemia: a paradigm for oncoprotein-targeted cure

PP Pandolfi, Z Chen - Cancer cell, 2017 - cell.com
Recent clinical trials have demonstrated that the immense majority of acute promyelocytic
leukemia (APL) patients can be definitively cured by the combination of two targeted …

The isomerase PIN1 controls numerous cancer-driving pathways and is a unique drug target

XZ Zhou, KP Lu - Nature Reviews Cancer, 2016 - nature.com
Targeted drugs have changed cancer treatment but are often ineffective in the long term
against solid tumours, largely because of the activation of heterogeneous oncogenic …

Acute Promyelocytic Leukemia: A Constellation of Molecular Events around a Single PML-RARA Fusion Gene

A Liquori, M Ibañez, C Sargas, MÁ Sanz, E Barragán… - Cancers, 2020 - mdpi.com
Although acute promyelocytic leukemia (APL) is one of the most characterized forms of
acute myeloid leukemia (AML), the molecular mechanisms involved in the development and …

SUMO5, a novel poly-SUMO isoform, regulates PML nuclear bodies

YC Liang, CC Lee, YL Yao, CC Lai, ML Schmitz… - Scientific reports, 2016 - nature.com
Promyelocytic leukemia nuclear bodies (PML-NBs) are PML-based nuclear structures that
regulate various cellular processes. SUMOylation, the process of covalently conjugating …